LUCD
Lucid Diagnostics Inc.
-0.05 (-6.08%)0.79USD574K成交股數160M市值–本益比(近四季)29.3股價營收比+26.7%營收年增(近四季)2026-11-11下次財報
內部人交易 SEC Form 4 · 董事、高階主管與持股 10% 以上股東 · 交易後兩個營業日內申報
買賣點與股價近一年
● 公開市場買進 · ● 公開市場賣出 · 空心 = 10b5-1 預設計畫(事先排程,不代表當下看法)。近一年,只畫 P / S 兩種代碼。
統計
| 近 90 天 買進筆數 · 金額 · 人數 | 0 · 0.00 · 0 |
|---|---|
| 近 90 天 賣出筆數 · 金額 · 人數 | 0 · 0.00 · 0 |
| 其中 10b5-1 計畫賣出 | 0 筆 |
| 近 180 天 買進 · 賣出金額 | 245K · 0.00 |
| 近 180 天 淨額 | 245K |
公開市場買進(P)是內部人自掏腰包,通常比賣出更有資訊含量 —— 賣出的理由很多(繳稅、分散、買房),買進的理由只有一個。
10b5-1 是事先排定的交易計畫,執行時點不反映當下看法。獲配股票(A)、繳稅扣股(F)、選擇權執行(M)是薪酬流程,不是意見。
| 交易日 | 申報日 | 申報人 | 職稱 | 代碼 | 股數 | 價格 | 金額 | 交易後持股 | 原件 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-05-20 | 05-21 | Matheis Dennis | Director | P 公開市場買進 | 245K | 1.00 | 245K | 1.0M | SEC |
| 2026-02-20 | 02-24 | O'Neil Shaun | President and COO | A 獲配股票 | 620K | – | – | 1.4M | SEC |
| 2026-02-20 | 02-24 | MCGRATH DENNIS M | Chief Financial Officer | A 獲配股票 | 470K | – | – | 1.8M | SEC |
| 2026-02-20 | 02-24 | Cox James L | Director | A 獲配股票 | 123K | – | – | 405K | SEC |
| 2026-02-20 | 02-24 | Lapidus Stanley | Director | A 獲配股票 | 123K | – | – | 337K | SEC |
| 2026-02-20 | 02-24 | PALUMBO JOHN R | Director | A 獲配股票 | 123K | – | – | 338K | SEC |
| 2026-02-20 | 02-24 | SOKOLOV JACQUE J | Director | A 獲配股票 | 123K | – | – | 320K | SEC |
| 2026-02-20 | 02-24 | Sparks Ronald M | Director | A 獲配股票 | 123K | – | – | 320K | SEC |
| 2026-02-20 | 02-24 | White Debra | Director | A 獲配股票 | 123K | – | – | 236K | SEC |
| 2026-02-20 | 02-24 | Matheis Dennis | Director | A 獲配股票 | 123K | – | – | 788K | SEC |
| 2026-02-20 | 02-24 | Aklog Lishan | Chief Executive Officer | A 獲配股票 | 2.2M | – | – | 3.6M | SEC |
| 2026-02-20 | 02-24 | Gordon Michael Adam | General Counsel and Secretary | A 獲配股票 | 300K | – | – | 1.0M | SEC |
| 2025-08-20 | 08-22 | Matheis Dennis | Director | P 公開市場買進 | 100K | 1.02 | 102K | 665K | SEC |
| 2025-05-22 | 05-23 | Matheis Dennis | Director | P 公開市場買進 | 33.2K | 1.32 | 44K | 565K | SEC |
| 2025-05-22 | 05-22 | Matheis Dennis | Director | P 公開市場買進 | 33.2K | 1.32 | 44K | 350K | SEC |
| 2025-05-21 | 05-23 | Matheis Dennis | Director | P 公開市場買進 | 130K | 1.32 | 171K | 532K | SEC |
| 2025-05-21 | 05-22 | Matheis Dennis | Director | P 公開市場買進 | 130K | 1.32 | 171K | 317K | SEC |
| 2025-05-20 | 05-23 | Matheis Dennis | Director | P 公開市場買進 | 187K | 1.30 | 243K | 403K | SEC |
| 2025-05-20 | 05-22 | Matheis Dennis | Director | P 公開市場買進 | 187K | 1.30 | 243K | 187K | SEC |
| 2025-02-20 | 02-21 | Gordon Michael Adam | General Counsel and Secretary | A 獲配股票 | 300K | – | – | 700K | SEC |
| 2025-02-20 | 02-21 | MCGRATH DENNIS M | Chief Financial Officer | A 獲配股票 | 300K | – | – | 1.3M | SEC |
| 2025-02-20 | 02-21 | Cox James L | Director | A 獲配股票 | 113K | – | – | 282K | SEC |
| 2025-02-20 | 02-21 | Matheis Dennis | Director | A 獲配股票 | 113K | – | – | 163K | SEC |
| 2025-02-20 | 02-21 | Lapidus Stanley | Director | A 獲配股票 | 113K | – | – | 214K | SEC |
| 2025-02-20 | 02-21 | SOKOLOV JACQUE J | Director | A 獲配股票 | 113K | – | – | 197K | SEC |
| 2025-02-20 | 02-21 | Aklog Lishan | Chief Executive Officer | A 獲配股票 | 300K | – | – | 1.5M | SEC |
| 2025-02-20 | 02-21 | O'Neil Shaun | President and COO | A 獲配股票 | 300K | – | – | 827K | SEC |
| 2025-02-20 | 02-21 | Sparks Ronald M | Director | A 獲配股票 | 113K | – | – | 197K | SEC |
| 2025-02-20 | 02-21 | White Debra | Director | A 獲配股票 | 113K | – | – | 113K | SEC |
| 2024-05-07 | 05-08 | MCGRATH DENNIS M | Chief Financial Officer | A 獲配股票 | 400K | – | – | 1.0M | SEC |
| 2024-05-07 | 05-08 | Aklog Lishan | Chief Executive Officer | A 獲配股票 | 400K | – | – | 1.2M | SEC |
| 2024-05-07 | 05-08 | O'Neil Shaun | President and COO | A 獲配股票 | 400K | – | – | 527K | SEC |
| 2024-05-07 | 05-08 | Gordon Michael Adam | General Counsel and Secretary | A 獲配股票 | 400K | – | – | 400K | SEC |
| 2024-02-15 | 02-20 | PAVmed Inc. | TenPercentOwner | J 其他 | 3.3M | – | – | 31.3M | SEC |
| 2024-01-26 | 01-30 | PAVmed Inc. | TenPercentOwner | J 其他 | 3.3M | 1.40 | 4.7M | 34.6M | SEC |
| 2023-09-26 | 09-27 | Lapidus Stanley | Director | S 公開市場賣出(10b5-1) | 10.0K | 1.47 | 15K | 121K | SEC |
| 2023-09-26 | 09-27 | Lapidus Stanley | Director | S 公開市場賣出(10b5-1) | 10.0K | 1.43 | 14K | 111K | SEC |
| 2023-09-26 | 09-27 | Lapidus Stanley | Director | S 公開市場賣出(10b5-1) | 9.7K | 1.45 | 14K | 102K | SEC |
| 2023-09-25 | 09-27 | Lapidus Stanley | Director | S 公開市場賣出(10b5-1) | 200 | 1.43 | 286.00 | 131K | SEC |
| 2023-09-21 | 09-27 | Lapidus Stanley | Director | S 公開市場賣出(10b5-1) | 100 | 1.44 | 144.00 | 132K | SEC |
| 2023-09-21 | 09-22 | Lapidus Stanley | Director | S 公開市場賣出 | 100 | 1.44 | 144.00 | 132K | SEC |
| 2023-09-20 | 09-27 | Lapidus Stanley | Director | S 公開市場賣出(10b5-1) | 412 | 1.44 | 593.28 | 132K | SEC |
| 2023-09-20 | 09-27 | Lapidus Stanley | Director | S 公開市場賣出(10b5-1) | 3.4K | 1.45 | 5K | 132K | SEC |
| 2023-09-20 | 09-22 | Lapidus Stanley | Director | S 公開市場賣出 | 412 | 1.44 | 593.28 | 132K | SEC |
| 2023-09-20 | 09-22 | Lapidus Stanley | Director | S 公開市場賣出 | 3.4K | 1.45 | 5K | 132K | SEC |
| 2022-11-30 | 04-13 | PAVmed Inc. | TenPercentOwner | J 其他 | 222K | 2.48 | 550K | 29.5M | SEC |
| 2022-11-30 | 04-13 | PAVmed Inc. | TenPercentOwner | J 其他 | 1.1M | 1.84 | 2.1M | 29.1M | SEC |
| 2022-11-30 | 04-13 | PAVmed Inc. | TenPercentOwner | J 其他 | 198K | 2.78 | 549K | 29.3M | SEC |
| 2022-11-30 | 04-13 | PAVmed Inc. | TenPercentOwner | J 其他 | 331K | 1.66 | 550K | 29.8M | SEC |
| 2022-11-30 | 04-13 | PAVmed Inc. | TenPercentOwner | J 其他 | 1.5M | 1.84 | 2.7M | 31.3M | SEC |
| 2022-11-30 | 12-02 | PAVmed Inc. | TenPercentOwner | J 其他 | 1.1M | 1.84 | 2.1M | 40.3M | SEC |
| 2022-11-30 | 12-02 | PAVmed Inc. | TenPercentOwner | J 其他 | 198K | 2.78 | 549K | 40.5M | SEC |
| 2022-11-30 | 12-02 | PAVmed Inc. | TenPercentOwner | J 其他 | 222K | 2.48 | 550K | 40.7M | SEC |
| 2022-11-30 | 12-02 | PAVmed Inc. | TenPercentOwner | J 其他 | 331K | 1.66 | 550K | 41.0M | SEC |
| 2022-11-30 | 12-02 | PAVmed Inc. | TenPercentOwner | J 其他 | 1.5M | 1.84 | 2.7M | 42.5M | SEC |
| 2022-09-20 | 09-22 | Lapidus Stanley | Director | S 公開市場賣出 | 17.0K | 1.71 | 29K | 152K | SEC |
| 2022-09-20 | 09-22 | Lapidus Stanley | Director | S 公開市場賣出 | 16.9K | 1.70 | 29K | 135K | SEC |
| 2022-01-07 | 01-10 | Aklog Lishan | Chief Executive Officer | A 獲配股票 | 60.0K | – | – | 624K | SEC |
| 2022-01-07 | 01-10 | MCGRATH DENNIS M | Chief Financial Officer | A 獲配股票 | 60.0K | – | – | 624K | SEC |
| 2021-10-18 | 10-20 | PAVmed Inc. | TenPercentOwner | P 公開市場買進 | 571K | 14.00 | 8.0M | 27.9M | SEC |
| 2021-10-18 | 10-20 | Sparks Ronald M | Director | A 獲配股票 | 84.7K | – | – | 84.7K | SEC |
機構持股(13F) 管理規模 1 億美元以上的機構,每季末後 45 天內申報 · 最新 2026-06-30
前 25 大持有機構季末市值 · 與前一季股數比較
| 機構 | 持股 | 季末市值 | 股數季變化 | 動作 |
|---|---|---|---|---|
| Alyeska Investment Group, L.P. | 8.9M | 9.5M | 新進 | 新進 |
| BlackRock, Inc. | 8.4M | 9.0M | 新進 | 新進 |
| VANGUARD CAPITAL MANAGEMENT LLC | 6.6M | 7.0M | 新進 | 新進 |
| Two Seas Capital LP | 6.0M | 6.4M | 新進 | 新進 |
| MASTERS CAPITAL MANAGEMENT LLC | 4.0M | 4.3M | 新進 | 新進 |
| Aberdeen Group plc | 3.8M | 4.1M | 新進 | 新進 |
| GEODE CAPITAL MANAGEMENT, LLC | 3.8M | 4.1M | 新進 | 新進 |
| STATE STREET CORP | 2.4M | 2.6M | 新進 | 新進 |
| FIRST MANHATTAN CO. LLC. | 2.2M | 2.3M | 新進 | 新進 |
| WELLS FARGO & COMPANY/MN | 2.1M | 2.2M | 新進 | 新進 |
| Russell Investments Group, Ltd. | 1.7M | 1.8M | 新進 | 新進 |
| NORTHERN TRUST CORP | 1.2M | 1.3M | 新進 | 新進 |
| PERKINS CAPITAL MANAGEMENT INC | 1.1M | 1.2M | 新進 | 新進 |
| VANGUARD FIDUCIARY TRUST CO | 1.1M | 1.1M | 新進 | 新進 |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 1.0M | 1.1M | 新進 | 新進 |
| UBS Group AG | 845K | 904K | 新進 | 新進 |
| AQR CAPITAL MANAGEMENT LLC | 723K | 774K | 新進 | 新進 |
| RAYMOND JAMES FINANCIAL INC | 577K | 618K | 新進 | 新進 |
| Lido Advisors, LLC | 447K | 478K | 新進 | 新進 |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 325K | 348K | 新進 | 新進 |
| XML Financial, LLC | 323K | 346K | 新進 | 新進 |
| Bank of New York Mellon Corp | 302K | 323K | 新進 | 新進 |
| BANK OF MONTREAL /CAN/ | 290K | 310K | 新進 | 新進 |
| Nuveen, LLC | 195K | 209K | 新進 | 新進 |
| Tripletail Wealth Management, LLC | 183K | 196K | 新進 | 新進 |
持有機構數近 12 季
每季 13F 申報中持有本股的機構家數;綠柱 = 比上季少。機構數是「有多少人在船上」,不是「買了多少」。
| 持有機構 · 季變化 | 116 +13 |
|---|---|
| 新進 / 出清 / 加碼 / 減碼 | 116 / 0 / 0 / 0 |
| 機構合計持股 · 佔流通股 | 61.4M · 30.2% |
| 合計季末市值 | 65.6M |
13F 只申報多頭部位(含可轉債與選擇權,選擇權這裡已排除),不申報放空,也不申報 1 億美元以下的機構。同一集團多個申報主體會各算一家。
放空餘額 FINRA 每月兩次(15 日與月底結算)· 最新 2026-08-31
空單佔流通股近 13 個月
FINRA 每月兩次結算的空單餘額佔流通股數的比例,近 13 個月。滑到柱子看股數與回補天數。
最新一期
| 空單股數 | 11.9M |
|---|---|
| 與上期比 | -7.3% |
| 佔流通股數 | 5.85% |
| 日均成交量 | 819K |
| 回補天數 | 14.5 天 |
空單佔比 10% 以上算高、20% 以上算很高(這是通行的說法,不是本站的判斷)。回補天數 = 空單 ÷ 日均量,天數愈長,空方要出場時愈容易推升股價。
放空餘額是「有人借股票賣掉還沒還」的存量,不代表看空的人正在加碼;避險基金做多空配對時也會產生空單。
| 結算日 | 空單股數 | 與上期比 | 佔流通股 | 日均量 | 回補天數 |
|---|---|---|---|---|---|
| 2026-08-31 | 11.9M | -7.3% | 5.85% | 819K | 14.5 |
| 2026-08-14 | 12.8M | +5.8% | 6.31% | 1.0M | 12.3 |
| 2026-07-31 | 12.1M | +11.3% | 5.97% | 1.5M | 8.3 |
| 2026-07-15 | 10.9M | +15.6% | 5.36% | 1.6M | 7.0 |
| 2026-06-30 | 9.4M | +26.8% | 4.64% | 2.6M | 3.6 |
| 2026-06-15 | 7.4M | +21.6% | 3.66% | 844K | 8.8 |
| 2026-05-29 | 6.1M | -7.8% | 3.01% | 1.1M | 5.8 |
| 2026-05-15 | 6.6M | +11.4% | 3.26% | 867K | 7.6 |
| 2026-04-30 | 5.9M | -4.6% | 2.92% | 960K | 6.2 |
| 2026-04-15 | 6.2M | +4.9% | 3.06% | 729K | 8.5 |
| 2026-03-31 | 5.9M | +2.4% | 2.92% | 566K | 10.5 |
| 2026-03-13 | 5.8M | -13.8% | 2.85% | 697K | 8.3 |
| 2026-02-27 | 6.7M | -7.4% | 3.31% | 783K | 8.6 |
| 2026-02-13 | 7.3M | +3.6% | 3.58% | 814K | 8.9 |
| 2026-01-30 | 7.0M | +84.7% | 3.45% | 4.3M | 1.6 |
| 2026-01-15 | 3.8M | -20.0% | 1.87% | 519K | 7.3 |
| 2025-12-31 | 4.7M | +10.5% | 2.34% | 662K | 7.2 |
| 2025-12-15 | 4.3M | +8.8% | 2.11% | 711K | 6.0 |
| 2025-11-28 | 3.9M | +30.5% | 1.94% | 714K | 5.5 |
| 2025-11-14 | 3.0M | +3.1% | 1.49% | 612K | 5.0 |
| 2025-10-31 | 2.9M | -20.3% | 1.44% | 670K | 4.4 |
| 2025-10-15 | 3.7M | -31.1% | 1.81% | 1.7M | 2.1 |
| 2025-09-30 | 5.3M | -12.1% | 2.63% | 969K | 5.5 |
| 2025-09-15 | 6.1M | +15.6% | 2.99% | 2.2M | 2.8 |
| 2025-08-29 | 5.3M | -3.9% | 2.59% | 974K | 5.4 |
| 2025-08-15 | 5.5M | +3.6% | 2.69% | 568K | 9.6 |